Algaeboy
3 days ago
Mike,
I’ve mistakenly traded very little over the years…Treated this one as a buy/hold option, particularly after the late 2018 info about the molecule discovery, and was also hopeful that something would happen first with Mastitis, and then then the company would have some cash, and away we would go…A series of conversations I’ve had over the years, along with other a few other things, with those in the poultry industry in NOCAL and southern Oregon where I resided at the time, made me understand the industry’s DESPERATE need for a natural product like the Algae produced by ZIVO…Mastitis, Coccidiosis,Inflammation ,Bird flu etc, are VERY SERIOUS issues for all involved at every level of the poultry business world, and have been for years…my thinking was the Proalgazyme was going to become a legit natural option by 2022/23…SILLY ME!!…antibiotic treatments, are simply small Band-Aids on large wounds for the industry, and that will not change anytime soon… So I will just have to sit, hope and wait, but at this point, I’m expecting nothing, and that’s what it looks like we’re gonna get from ZIVO.
Tony53711
6 days ago
I picked a date in 2014 and found this. You two must be in this deep buying at whatever this was trading at in 2014. Doesn’t sound like “swing trading” to me. Almost any other stock is better “swing trading” than Zivo.
Amigo Mike Free
05/24/14 2:30 PM
Post #3,306
Re: #3,303: Mags has no choice but to buy at
Dunno where this theory comes from that he has to buy to save his investment. What difference does it make if the stock drops to a penny but you know what you have and what it's worth ? Markets go both ways.
Quite the contrary actually. He doesn't need to do any such thing.
First he is a member of HEP Investments. The security for the notes owned by HEP Investments is ALL THE ASSETS OF THE COMPANY. All he has to do is demand payment, foreclose and own it all himself and with his partner. Then he could finish up the needed testing himself and take all the rewards for himself.
He also has millions of cheap warrants to get more stock. Doesn't have to buy the market.
Clearly we all moan about stock price but reality is the value of the company increases with every confirmation of the bioactive. Stock price will get where it needs to be when real investors find the name and HEPI delivers on partner deals. Personally I'd prefer HEPI land Zoetis, start the partner discussion on canine with another major and then sell the company.
Amigo Mike
profile icon
weazelboy Free
05/24/14 10:03 AM
Post #3,305
Re: #3,304: Amigo and Hypi, thanks for your response! What
That is the option we ALL should be wanting...a total buyout. It removes all speculation IMO. If they like what they see and the potential revenue opportunities are in the hundreds of millions (or billion)...writing a one-time check for several hundred millions is pocket change for a company that big these days.
In this scenario though, there is no time to accumulate for the run-up. As the purchase price of the company will determine the share price and stock would seemingly open at that determined price the day of said announcement. JMHO.
Of course, at this point...I'll take anything that is revenue generating! LOL.
weazelboy
3 weeks ago
New Sch13D just hit for Strome. Between his 4 entities and him personally, he owns 486,174 shares (2nd largest holder).
So, top 3 holders own 1,330,117 of roughly 2.75 million o/s.
https://www.sec.gov/Archives/edgar/data/1101026/000117494724000523/ea0203503-13da7strome_zivo.htm
Haven't been paying really close attention here lately...and have been out of town a lot...but noticed that HEP Investments/Yaldoo filed an updated Sch 13D a few weeks ago. First one in a while, from what I can see.
Shows 488,785 shares owned which is 17.8% of outstanding (putting o/s roughly 2.75ish million).
That means between Yaldoo 488,785 and Mags 355,158 alone they hold 844k of that 2.75 million. Add in Strome (his last Sch 13 was pre-latest reverse)...but that means insiders hold close to 50% of the o/s in total if you add them all up (not taking the time to do this individually, just a rough guesstimate).
So, most of o/s is still in tight hands now with Armistice out of picture until their warrants come in the $$ at 16.80. By no means does that give me a signal to try and time a bottom here and re-add to position, but the original thesis is still in play if daily chart can base and curl up (also barring no further dilution, which is the part that is least likely, as they need $$ again).
weazelboy
1 month ago
Haven't been paying really close attention here lately...and have been out of town a lot...but noticed that HEP Investments/Yaldoo filed an updated Sch 13D a few weeks ago. First one in a while, from what I can see.
Shows 488,785 shares owned which is 17.8% of outstanding (putting o/s roughly 2.75ish million).
That means between Yaldoo 488,785 and Mags 355,158 alone they hold 844k of that 2.75 million. Add in Strome (his last Sch 13 was pre-latest reverse)...but that means insiders hold close to 50% of the o/s in total if you add them all up (not taking the time to do this individually, just a rough guesstimate).
So, most of o/s is still in tight hands now with Armistice out of picture until their warrants come in the $$ at 16.80. By no means does that give me a signal to try and time a bottom here and re-add to position, but the original thesis is still in play if daily chart can base and curl up (also barring no further dilution, which is the part that is least likely, as they need $$ again).
Amigo Mike
1 month ago
Agree,
I looked at the action. Almost all trades on the offer. So that's a positive. But can't last forever without news.
I assume you saw HEP Investments (Laith Yaldoo) post an updated 13D yesterday for 488K shares. Guess his group still holding a pile of stock. It is amazing to me he files a 13D and still holds. If you don't know, filing 13D is an indication that you intend to influence company mgmt vs 13G that is declaring passive intent.
Yaldoo IMO ... was and is part of the problem rather than the solution. Although now ZIVO has a CEO that has a clue. Yeah he funded ZIVO for several years but the condition of his funding was Dahl being CEO and his money allowed him to attend BoD meetings. He has zero background in bio/agtech science anything. And neither did Dahl. Of course now he's losing his shirt on this investment with ZIVO being YEARS behind where it should be.
There are tons of thing ZIVO could be doing now that they aren't. ZIVOLife for instance, can't wait to see the numbers on that. Not expecting much. But gut health, joint health, inflammation, sports recovery, covid .... the possibilities are massive. LIke I said I would have done side by side on glucosamine. CRP is an easy blood test for inflammation. I'd directly be comparing against AG1 that you see all over the place now. Of course there is that problem of can't produce in massive quantities. Although my due dilly yields pics of Alimenta's grow facility appears to have expanded with new raceway pond(s). There is at least 1 new one from last I saw and maybe more. ZIVO could easily update website on production progress with little to no effort.
But of course the elephant in the room is the coccidiosis license with one of the big boyz. Tic Toc .......... I can understand ZIVO being mum on that, but there are other things that can be shared with investors.
A couple of 1k+ offers at 8.99 to start the day.... =) I am still sitting patient with my swing position from 60 cents and already posted the sell to cover the investment so sitting on house money and waiting. And still of the opinion this thing should be sitting at $20 with the final coccidiosis results proven which doesn't even put the ZIVO market cap back where it sat historically.
Amigo Mike